ONC Competitors & Alternatives
Compare BeiGene, Ltd. with similar stocks in the same industry
Biotechnology
ONC
Main Stock$371.98
Tradestie Score
38
Market Cap
$36.81B
P/E Ratio
67.1
Revenue Growth
0.3%
Analyst Upside
+16.4%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REGN
Regeneron Pharmaceuticals Inc
|
$828.50
|
$63.59B | 20.6 | 40 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$236.01
|
$60.38B | 41.2 | 42 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$1011.11
|
$46.96B | 39.7 | 33 | Compare |
|
INSM
Insmed, Inc.
|
$123.98
|
$31.13B | - | 34 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$112.82
|
$24.57B | - | 29 | Compare |
|
GMAB
Genmab A/S ADS
|
$33.02
|
$19.56B | 26.3 | 35 | Compare |
|
INCY
Incyte Genomics Inc
|
$127.98
|
$16.93B | 16.3 | 45 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$61.33
|
$15.70B | 33.0 | 40 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$12.73
|
$15.22B | - | 46 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$251.95
|
$12.36B | 19.4 | 50 | Compare |
More ONC Analysis
Data updated: Aug 25, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry